Zenni Optical vs Solv Health
Side-by-side comparison of AI visibility scores, market position, and capabilities
San Francisco pioneer DTC online eyewear at $6.95+ complete glasses with 50M+ pairs sold; privately-held disrupting traditional optical retail competing with Warby Parker and EyeBuyDirect for affordable prescription glasses online.
About
Zenni Optical is a San Francisco-based direct-to-consumer online eyewear retailer — privately held, founded in 2003 by Jing Wang and Julia Zhen — pioneering the online prescription glasses market by offering hundreds of frame styles with prescription lens fulfillment starting from as low as $6.95, making vision correction accessible at a fraction of the $200-800+ price of traditional optical retail. Estimated at $400+ million in annual revenue with 50+ million pairs of glasses sold to 50+ million customers in over 50 countries, Zenni's low-cost manufacturing (frames produced at owned factories in China) and direct-to-consumer model (no distributor or retailer markup layers) enable the dramatic price advantage over LensCrafters, Sunglass Hut, and independent opticians that made Zenni one of the first successful DTC disruptors.
Solv Health is a same-day appointment booking platform for urgent care, primary care, and telehealth, offering patients transparent wait times and insurance-aware scheduling.
About
Solv Health operates a consumer-facing booking platform that aggregates same-day availability from urgent care centers, primary care practices, and telehealth providers — giving patients the ability to find and book immediate care without calling multiple clinics or waiting in walk-in lines. The platform displays real-time wait times, insurance acceptance, and directions, making the experience of finding immediate care as simple as booking a restaurant reservation.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.